Pukang biological freeze-dried human rabies vaccine clinical trial accepted

2023年06月29Independently developed by Zhejiang Pukang Biotechnology Co., LTD"Freeze-dried human rabies vaccine (human diploid cells)" was officially accepted by the State Drug Administration for clinical trial application (acceptance number: CXSL2300441)。

The acquisition of the clinical trial application acceptance number marks a solid step in the development of new products of Pukang。